UCLA https://www.uclahealth.org received $29 Million to establish the Dr. Allen and Charlotte Ginsburg Center for Precision Genomic Medicine to use to advance research and enhance patient care for genetic conditions. Physicians will work together to examine the role of genetics in disease and then develop therapies to improve patients’ lives.
The new Center will build on UCLA’s efforts in precision health to leverage large data sets and innovative genomic technologies such as CRISPR engineering, to improve diagnosis and treatment for a wide variety of genetic disorders which will include rare diseases and more common illnesses.
The Center will utilize the expertise of physicians and researchers from the UCLA Institute for Precision Health and the human genetics departments as well as from faculty specializing in medical genetics, rare diseases, computational medicine, and other disciplines.
Engineering at UCLA also has a Center called the Institute for the Risk Sciences https://www.risksciences.ucla.edu/smart-health dedicated to research, development, and application of technology and methods for predicting and reducing risk, improving precision, enhancing resilience, and improving the quality of healthcare.
The aim of the Center is to address high impact projects using novel approaches and methods across multiple disciplines including engineering, computer science, biomedical informatics, decision theory, sociology, psychology, and business.
The Center is involved in research on mobile devices and sensors, remote health monitoring devices, geriatrics smart home care, critical care, smart alarms, precision medicine, healthcare big data analytics, and safety and quality improvement.